Low High-Density Lipoprotein (Low HDL) and Its Relationship to Cardiovascular Diseases

  Share :          
  258

High-Density Lipoprotein (Low HDL) and Its Relationship to Cardiovascular Diseases A Scientific Article in Biochemistry and Preventive Medicine 1. Introduction High-density lipoprotein (HDL) is one of the major types of lipoproteins found in human blood plasma. It is commonly known as "good cholesterol" because of its important role in transporting excess cholesterol from peripheral tissues and cells to the liver, where it can be metabolized and eliminated from the body. HDL plays an essential role in maintaining biochemical lipid balance and supporting cardiovascular health. Therefore, low levels of HDL in the blood are considered an important marker associated with an increased risk of cardiovascular diseases. Low HDL, also known as hypoalphalipoproteinemia, may occur due to several factors, including genetic disorders, metabolic abnormalities, physical inactivity, obesity, smoking, and diabetes mellitus. From a biochemical perspective, low HDL is associated with disturbances in reverse cholesterol transport, which is the process responsible for removing excess cholesterol from peripheral tissues and transporting it to the liver. Understanding the causes and mechanisms of low HDL is important for explaining the relationship between lipid metabolism disorders, atherosclerosis, and cardiovascular diseases. 2. Biochemical Structure of High-Density Lipoprotein (HDL) HDL consists of a combination of lipids and proteins. It is characterized by its relatively high protein content and lower lipid content compared with other lipoproteins. Its main components include: Proteins: The major protein component is Apolipoprotein A-I (ApoA-I), which plays an essential role in HDL formation and function. Phospholipids: These form the outer surface of HDL particles. Free Cholesterol: Present mainly on the surface of the particle. Cholesteryl Esters: Located primarily in the internal core of HDL. Triglycerides: Present in smaller amounts compared with triglyceride-rich lipoproteins. This structural organization allows HDL to transport cholesterol through the bloodstream. 3. Biological Functions of HDL HDL performs several important biological functions in the human body. First: Reverse Cholesterol Transport Reverse cholesterol transport is considered the most important function of HDL. During this process, HDL collects excess cholesterol from peripheral tissues and cells, particularly from macrophages in arterial walls, and transports it toward the liver. This process involves several steps: The liver and intestine produce Apolipoprotein A-I (ApoA-I). ApoA-I interacts with the ATP-binding cassette transporter A1 (ABCA1), allowing cholesterol and phospholipids to move from cells to ApoA-I. Nascent HDL particles are formed. The enzyme Lecithin-Cholesterol Acyltransferase (LCAT) converts free cholesterol into cholesteryl esters. Cholesterol is transported to the liver directly or indirectly for further metabolism and elimination. Second: Antioxidant Effects HDL contributes to reducing oxidative stress by limiting certain oxidative processes involving lipids and lipoproteins. This function may help protect blood vessels from oxidative damage. Third: Anti-inflammatory Effects Normal, functional HDL contributes to regulating inflammatory responses and reducing inflammatory activity within blood vessels. Fourth: Endothelial Protection HDL supports the normal function of endothelial cells, which form the inner lining of blood vessels. It also contributes to the regulation of nitric oxide (NO) production, which helps blood vessels relax and maintain normal blood flow. 4. Definition of Low HDL Low HDL refers to a lower-than-desirable concentration of cholesterol carried by high-density lipoproteins in the blood. Commonly used clinical thresholds for low HDL in adults are: Men: Less than 40 mg/dL. Women: Less than 50 mg/dL. An HDL level of 60 mg/dL or higher has traditionally been considered favorable, although it does not guarantee protection against cardiovascular diseases. These thresholds should be interpreted according to individual health conditions, cardiovascular risk factors, and clinical guidelines. 5. Causes of Low HDL Several factors can contribute to decreased HDL levels in the blood. 1. Obesity Obesity, particularly the accumulation of visceral fat around internal organs, causes metabolic disturbances that affect lipid metabolism. It may increase the production of triglyceride-rich lipoproteins and contribute to decreased HDL levels and increased triglycerides. 2. Physical Inactivity Lack of regular physical activity affects lipid metabolism and energy balance. A sedentary lifestyle may contribute to increased triglycerides and reduced HDL concentrations. 3. Diabetes Mellitus Insulin resistance increases the breakdown of stored fat in adipose tissue, resulting in the release of free fatty acids into the bloodstream. These fatty acids reach the liver, where they contribute to triglyceride synthesis and increased production of very-low-density lipoproteins (VLDL). Increased VLDL promotes lipid exchange between lipoproteins through Cholesteryl Ester Transfer Protein (CETP). As a result, HDL particles become enriched with triglycerides and may undergo faster breakdown and clearance from the bloodstream, leading to decreased HDL levels. 4. Smoking Smoking increases oxidative stress and damages blood vessel function. It is also associated with reduced HDL levels and an increased risk of cardiovascular diseases. 5. Unhealthy Diet Excessive consumption of trans fats, added sugars, and refined carbohydrates may negatively affect lipid metabolism. These dietary habits can contribute to increased triglycerides and decreased HDL levels. 6. Genetic Factors Certain genetic mutations can interfere with HDL production, formation, or metabolism. Examples include: Apolipoprotein A-I deficiency. ABCA1 transporter defects. Tangier disease. These genetic abnormalities can significantly impair cholesterol transport and HDL formation. 6. Biochemical Mechanisms of Low HDL Understanding the biochemical mechanisms responsible for low HDL requires examining the metabolic processes involved in HDL formation and metabolism. First: Abnormalities in Apolipoprotein A-I (ApoA-I) ApoA-I is the main protein component of HDL and is essential for its formation and cholesterol transport functions. Reduced production or abnormal function of ApoA-I can impair HDL formation and decrease its concentration in the blood. Second: ABCA1 Transporter Dysfunction The ATP-binding cassette transporter A1 (ABCA1) transfers cholesterol and phospholipids from cells to ApoA-I. When this transporter is defective, cholesterol efflux from cells decreases, resulting in impaired HDL formation. Third: The Role of LCAT Enzyme Lecithin-Cholesterol Acyltransferase (LCAT) is an important enzyme involved in HDL maturation. It converts free cholesterol into cholesteryl esters, which move into the internal core of HDL particles. Reduced LCAT activity can interfere with HDL maturation and its ability to transport cholesterol efficiently. Fourth: The Role of CETP Cholesteryl Ester Transfer Protein (CETP) facilitates the exchange of cholesteryl esters from HDL with triglycerides from VLDL and LDL. When triglyceride levels are elevated, HDL particles may become enriched with triglycerides. These particles become more susceptible to enzymatic breakdown and faster removal from circulation, contributing to reduced HDL concentrations. 7. Relationship Between Low HDL and Atherosclerosis Low HDL is associated with an increased risk of atherosclerosis because HDL contributes to removing excess cholesterol from peripheral tissues and arterial macrophages. When HDL levels are reduced, reverse cholesterol transport may become less efficient, particularly when low HDL is accompanied by increased LDL and triglycerides. Atherosclerosis develops through several stages: Increased levels of atherogenic lipoproteins, particularly LDL. Entry and retention of LDL particles within the arterial wall. Chemical modifications of some LDL particles, including oxidation. [11/10/2026 11:12 PM] اللهم صل على محمد وال محمد: Activation of inflammatory cells within the arterial wall. Uptake of modified LDL by macrophages. Transformation of macrophages into foam cells. Accumulation of foam cells and formation of atherosclerotic plaques. Narrowing of arteries and reduction of blood flow. Normal, functional HDL may help reduce some of these processes. However, low HDL is not the only cause of atherosclerosis. Elevated LDL and other ApoB-containing lipoproteins play a direct and important role in disease development. 8. Relationship Between Low HDL and Cardiovascular Diseases Low HDL is associated with several cardiovascular diseases, including: 1. Coronary Artery Disease Low HDL, particularly when accompanied by elevated LDL and triglycerides, is associated with an increased risk of cholesterol accumulation in the coronary arteries. These arteries supply oxygen-rich blood to the heart muscle. 2. Myocardial Infarction Atherosclerotic plaque development and rupture may lead to the formation of a blood clot that blocks a coronary artery. This interrupts the supply of oxygen and blood to part of the heart muscle, resulting in myocardial infarction. 3. Stroke Lipid abnormalities associated with atherosclerosis may increase the risk of blockage in blood vessels supplying the brain. This can result in an ischemic stroke. 4. Peripheral Artery Disease The accumulation of atherosclerotic plaques in peripheral arteries can reduce blood circulation to the limbs, particularly the legs. Low HDL is considered a cardiovascular risk marker, but it is not by itself a direct cause of these diseases. 9. Laboratory Diagnosis of Low HDL Low HDL is detected through a blood test called the Lipid Profile. This test generally includes measurements of: Total Cholesterol: Measures the total cholesterol concentration in the blood. LDL Cholesterol: Measures or estimates cholesterol carried by low-density lipoproteins. HDL Cholesterol: Measures cholesterol carried by high-density lipoproteins. Triglycerides: Measures the concentration of triglycerides in the blood. These results help identify lipid abnormalities and assess cardiovascular risk. Additional laboratory tests may include: Fasting blood glucose. Glycated hemoglobin (HbA1c). Thyroid function tests. Liver function tests. Kidney function tests. These investigations help identify possible underlying causes of low HDL. 10. Prevention and Management of Low HDL The management of low HDL focuses on identifying the underlying cause and improving overall cardiovascular health. First: Regular Physical Exercise Regular physical activity improves lipid metabolism, reduces triglyceride levels, and may produce a modest increase in HDL. Second: Healthy Dietary Habits A healthy diet should include: Olive oil. Fish rich in omega-3 fatty acids. Nuts. Fresh vegetables and fruits. Whole grains. Legumes. It is also important to reduce trans fats, excessive saturated fats, and added sugars. Third: Maintaining a Healthy Body Weight Weight reduction, particularly the loss of excess visceral fat, improves insulin sensitivity, reduces triglycerides, and may improve the overall lipid profile. Fourth: Smoking Cessation Stopping smoking helps improve blood vessel health and reduce oxidative stress. Fifth: Diabetes Management Controlling blood glucose levels and improving insulin sensitivity can reduce metabolic disturbances associated with diabetes and abnormal lipid metabolism. Sixth: Pharmacological Treatment It is important to understand that treatment generally does not aim to increase HDL levels alone through medication. Clinical studies have not established that raising HDL pharmacologically, by itself, necessarily reduces cardiovascular events or mortality. Instead, treatment primarily focuses on lowering LDL and other atherogenic lipoproteins and controlling additional cardiovascular risk factors. 11. Biochemical and Medical Importance of Studying Low HDL Studying low HDL is important because it helps explain several essential biochemical processes and their relationship to cardiovascular health. The main benefits include: Understanding the mechanism of reverse cholesterol transport. Identifying the role of ApoA-I in HDL formation. Understanding the function of LCAT in HDL maturation. Explaining the role of CETP in lipid exchange between lipoproteins. Understanding the relationship between triglycerides and insulin resistance. Explaining the biochemical mechanisms involved in atherosclerosis. Supporting the early detection of lipid metabolism disorders. Improving preventive strategies against cardiovascular diseases. 12. Conclusion Low high-density lipoprotein (Low HDL) is an important biochemical abnormality associated with an increased risk of cardiovascular diseases, particularly when accompanied by elevated LDL cholesterol or triglyceride levels. HDL plays an essential role in reverse cholesterol transport and contributes to regulating inflammation, oxidative stress, and normal endothelial function. Low HDL may result from several factors, including obesity, insulin resistance, diabetes mellitus, smoking, physical inactivity, and genetic abnormalities. Understanding the biochemical mechanisms responsible for low HDL helps explain the relationship between lipid metabolism disorders and atherosclerosis. It also contributes to developing effective strategies for preventing cardiovascular diseases. Maintaining a healthy lifestyle, monitoring blood lipid levels, and controlling other cardiovascular risk factors remain important approaches to protecting heart and blood vessel Al-Mustaqbal University – The First University in Iraq